These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 29146242

  • 1. Acid-activatable oxidative stress-inducing polysaccharide nanoparticles for anticancer therapy.
    Yoo W, Yoo D, Hong E, Jung E, Go Y, Singh SVB, Khang G, Lee D.
    J Control Release; 2018 Jan 10; 269():235-244. PubMed ID: 29146242
    [Abstract] [Full Text] [Related]

  • 2. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.
    Zhao C, Cao W, Zheng H, Xiao Z, Hu J, Yang L, Chen M, Liang G, Zheng S, Zhao C.
    Int J Nanomedicine; 2019 Jan 10; 14():1597-1618. PubMed ID: 30880968
    [Abstract] [Full Text] [Related]

  • 3. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
    He W, Du Y, Zhou W, Wang T, Li M, Li X.
    Eur J Pharm Sci; 2020 Jul 01; 150():105340. PubMed ID: 32371069
    [Abstract] [Full Text] [Related]

  • 4. Acid-sensitive oxidative stress inducing and photoabsorbing polysaccharide nanoparticles for combinational anticancer therapy.
    Hong E, Hyun H, Lee H, Jung E, Lee D.
    Int J Pharm; 2020 Jan 25; 574():118893. PubMed ID: 31765773
    [Abstract] [Full Text] [Related]

  • 5. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.
    Zhang H, Sun Y, Huang R, Cang H, Cai Z, Sun B.
    Eur J Pharm Biopharm; 2018 Jul 25; 128():260-271. PubMed ID: 29733952
    [Abstract] [Full Text] [Related]

  • 6. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H, Sun M, Shi L, Zhu X, Huang W, Yan D.
    Biomater Sci; 2018 May 29; 6(6):1403-1413. PubMed ID: 29595843
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier.
    Tang Q, Cao B, Cheng G.
    Chem Commun (Camb); 2014 Feb 09; 50(11):1323-5. PubMed ID: 24343195
    [Abstract] [Full Text] [Related]

  • 11. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery.
    Du Y, Ling L, Ismail M, He W, Xia Q, Zhou W, Yao C, Li X.
    Int J Pharm; 2018 Oct 05; 549(1-2):352-362. PubMed ID: 30099214
    [Abstract] [Full Text] [Related]

  • 12. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
    Zhang F, Zhu G, Jacobson O, Liu Y, Chen K, Yu G, Ni Q, Fan J, Yang Z, Xu F, Fu X, Wang Z, Ma Y, Niu G, Zhao X, Chen X.
    ACS Nano; 2017 Sep 26; 11(9):8838-8848. PubMed ID: 28858467
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy.
    Ma W, Su H, Cheetham AG, Zhang W, Wang Y, Kan Q, Cui H.
    J Control Release; 2017 Oct 10; 263():102-111. PubMed ID: 28082170
    [Abstract] [Full Text] [Related]

  • 15. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
    Zhang H, Wang J, Mao W, Huang J, Wu X, Shen Y, Sui M.
    J Control Release; 2013 Mar 10; 166(2):147-58. PubMed ID: 23266448
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF, Yin W, Zha Z, Ke W, Wang Y, Chen W, Japir AAMM, Wang Y, Ge Z.
    J Control Release; 2019 Jun 10; 303():209-222. PubMed ID: 31026547
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acid-responsive endosomolytic polymeric nanoparticles with amplification of intracellular oxidative stress for prodrug delivery and activation.
    Lu N, Xi L, Zha Z, Wang Y, Han X, Ge Z.
    Biomater Sci; 2021 Jun 29; 9(13):4613-4629. PubMed ID: 34190224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.